Ubs Asset Management Americas Inc Cogent Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 207,198 shares of COGT stock, worth $3.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207,198
Previous 148,280
39.73%
Holding current value
$3.1 Million
Previous $888,000
67.45%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding COGT
# of Institutions
203Shares Held
117MCall Options Held
2.84MPut Options Held
828K-
Paradigm Biocapital Advisors LP New York, NY10.4MShares$155 Million3.47% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.49MShares$127 Million7.28% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$109 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$104 Million10.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.52MShares$97.6 Million0.0% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $984M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...